The Doxycycline Hyclate Capsules, cataloged under National Stock Number 6505-01-658-8734, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Avkare Llc. Government technical data includes 8 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BX.
| Parameter | Value |
|---|---|
| NSN | 6505-01-658-8734 |
| Primary Part Number | NDC50268-0278-15 |
| Item Name | Doxycycline Hyclate Capsules |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Avkare Llc |
| Status | ACTIVE |
| Administration | ORAL |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Features Provided | INDIVIDUALLY SEALED |
| Primary Container Type | CARD |
| Protective Storage Feature | CONTROLLED ROOM TEMPERATURE |
| Capsule Primary Container Content Quantity | 100.0 |
| Capsule Content Form | POWDER |
| Active Medicament Medicinal Strength | 100.0 MILLIGRAMS DOXYCYCLINE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BX |
| Part Number | Manufacturer |
|---|---|
| NDC50268-0278-15 PRIMARY | Avkare Llc (USA) |
| Reference | Meaning |
|---|---|
| 6505NCM163208 | 5/1 Secondary reference Defense Medical Standardization Board |
| 1435474 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-658-8734 is a Doxycycline Hyclate Capsules, manufactured by Avkare Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-658-8734 has 1 manufacturer part number on file: NDC50268-0278-15 (Avkare Llc).
Key specifications for NDC50268-0278-15: Administration: ORAL; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Features Provided: INDIVIDUALLY SEALED; Primary Container Type: CARD. 8 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.